New Aspects of Peanut and Tree Nut Allergy

Part of the Allergy Frontiers book series (ALLERGY, volume 5)

In recent years, as our understanding of peanut and tree nut allergy has increased, the potential for real therapies has expanded greatly. Hope for a cure for peanut and other food allergies is on the horizon. At the same time, the rates of peanut and tree nut allergy have continued to increase, and much remains to be learned about these potentially deadly allergies.

Recent news headlines have been filled with talk of a peanut allergy “epidemic.” Schools and airplanes have become battlegrounds over what measures need to be taken to ensure safety for peanut allergic patients. A 2005 news story about a peanut allergic Canadian teenager who died after kissing her boyfriend only amplified these concerns [1]. Behind these headlines, the data do point to an increase in peanut and tree nut allergy, along with other allergies. In the UK, admissions for ana-phylaxis from food allergy have increased by 500% since 1990 [2]. In the US, a survey conducted in 1997 and again in 2002 showed a doubling of the rate of peanut and tree nut allergy in children from 0.6 to 1.2%, mostly as a result of increases in peanut allergy, while the rates of peanut and tree nut allergy in adults did not change significantly. This suggests that overall rates will further increase in the coming years as these children become adults [3, 4].


Human Leukocyte Antigen Food Allergy Allergy Clin Immunol Food Challenge Peanut Allergy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Times N Y. Kiss Kills Teenager With Peanut Allergy. Nov 2005; webpage. Available at: Accessed June 16, 2007.
  2. 2.
    Gupta R, Sheikh A, Strachan DP, Anderson HR. Time trends in allergic disorders in the UK. Thorax. Jan 2007;62(1):91–96.CrossRefGoogle Scholar
  3. 3.
    Sicherer SH, Munoz-Furlong A, Sampson HA. Prevalence of peanut and tree nut allergy in the United States determined by means of a random digit dial telephone survey: a 5-year follow-up study. J Allergy Clin Immunol. Dec 2003;112(6):1203–1207.PubMedCrossRefGoogle Scholar
  4. 4.
    Grundy J, Matthews S, Bateman B, Dean T, Arshad SH. Rising prevalence of allergy to peanut in children: data from 2 sequential cohorts. J Allergy Clin Immunol. Nov 2002;110(5):784–789.PubMedCrossRefGoogle Scholar
  5. 5.
    Sicherer SH, Furlong TJ, DeSimone J, Sampson HA. The US peanut and tree nut allergy registry: characteristics of reactions in schools and day care. J Pediatr. Apr 2001;138(4):560–565.PubMedCrossRefGoogle Scholar
  6. 6.
    Sicherer SH, Noone SA, Munoz-Furlong A. The impact of childhood food allergy on quality of life. Ann Allergy Asthma Immunol. Dec 2001;87(6):461–464.PubMedGoogle Scholar
  7. 7.
    Bock SA, Munoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol. Jan 2001;107(1):191–193.PubMedCrossRefGoogle Scholar
  8. 8.
    Yunginger JW, Squillace DL, Jones RT, Helm RM. Fatal anaphylactic reactions induced by peanuts. Allergy Proc. Jul–Aug 1989;10(4):249–253.PubMedCrossRefGoogle Scholar
  9. 9.
    Sampson HA, Mendelson L, Rosen JP. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med. Aug 1992;327(6):380–384.PubMedGoogle Scholar
  10. 10.
    Pumphrey RS, Roberts IS. Postmortem findings after fatal anaphylactic reactions. J Clin Pathol. Apr 2000;53(4):273–276.PubMedCrossRefGoogle Scholar
  11. 11.
    Wensing M, Penninks AH, Hefle SL, Koppelman SJ, Bruijnzeel-Koomen CA, Knulst AC. The distribution of individual threshold doses eliciting allergic reactions in a population with peanut allergy. J Allergy Clin Immunol. Dec 2002;110(6):915–920.PubMedCrossRefGoogle Scholar
  12. 12.
    Hourihane JO, Dean TP, Warner JO. Peanut allergy in relation to heredity, maternal diet, and other atopic diseases: results of a questionnaire survey, skin prick testing, and food challenges. Bmj. Aug 1996;313(7056):518–521.PubMedGoogle Scholar
  13. 13.
    Strachan DP. Hay fever, hygiene, and household size. Bmj. Nov 1989;299(6710):1259–1260.PubMedCrossRefGoogle Scholar
  14. 14.
    McKeever TM, Lewis SA, Smith C, et al. Siblings, multiple births, and the incidence of allergic disease: a birth cohort study using the West Midlands general practice research database. Thorax. Oct 2001;56(10):758–762.PubMedCrossRefGoogle Scholar
  15. 15.
    Sudo N, Aiba Y, Oyama N, et al. Dietary nucleic acid and intestinal microbiota synergistically promote a shift in the Th1/Th2 balance toward Th1-skewed immunity. Int Arch Allergy Immunol. Oct 2004;135(2):132–135.PubMedCrossRefGoogle Scholar
  16. 16.
    Eder W, von Mutius E. Hygiene hypothesis and endotoxin: what is the evidence? Curr Opin Allergy Clin Immunol. Apr 2004;4(2):113–117.PubMedCrossRefGoogle Scholar
  17. 17.
    Prescott SL, Macaubas C, Smallacombe T, Holt BJ, Sly PD, Holt PG. Development of allergen-specific T-cell memory in atopic and normal children. Lancet. Jan 1999;353(9148):196–200.PubMedCrossRefGoogle Scholar
  18. 18.
    Woodfolk JA. T-cell responses to allergens. J Allergy Clin Immunol. Feb 2007;119(2):280–294; quiz 295–286.PubMedCrossRefGoogle Scholar
  19. 19.
    Rasanen M, Laitinen T, Kaprio J, Koskenvuo M, Laitinen LA. Hay fever–a Finnish nationwide study of adolescent twins and their parents. Allergy. Sep 1998;53(9):885–890.PubMedCrossRefGoogle Scholar
  20. 20.
    Lichtenstein P, Svartengren M. Genes, environments, and sex: factors of importance in atopic diseases in 7-9-year-old Swedish twins. Allergy. Nov 1997;52(11):1079–1086.PubMedCrossRefGoogle Scholar
  21. 21.
    Sicherer SH, Furlong TJ, Maes HH, Desnick RJ, Sampson HA, Gelb BD. Genetics of peanut allergy: a twin study. J Allergy Clin Immunol. Jul 2000;106(1 Pt 1):53–56.PubMedCrossRefGoogle Scholar
  22. 22.
    Marsh DG, Neely JD, Breazeale DR, et al. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science. May 1994;264(5162):1152–1156.PubMedCrossRefGoogle Scholar
  23. 23.
    Postma DS, Bleecker ER, Amelung PJ, et al. Genetic susceptibility to asthma–bronchial hyperresponsiveness coinherited with a major gene for atopy. N Engl J Med. Oct 1995;333(14):894–900.PubMedCrossRefGoogle Scholar
  24. 24.
    Noguchi E, Shibasaki M, Arinami T, et al. Evidence for linkage between asthma/atopy in childhood and chromosome 5q31-q33 in a Japanese population. Am J Respir Crit Care Med. Nov 1997;156(5):1390–1393.PubMedGoogle Scholar
  25. 25.
    Martinez FD, Solomon S, Holberg CJ, Graves PE, Baldini M, Erickson RP. Linkage of circulating eosinophils to markers on chromosome 5q. Am J Respir Crit Care Med. Dec 1998;158(6):1739–1744.PubMedGoogle Scholar
  26. 26.
    Palmer LJ, Daniels SE, Rye PJ, et al. Linkage of chromosome 5q and 11q gene markers to asthma-associated quantitative traits in Australian children. Am J Respir Crit Care Med. Dec 1998;158(6):1825–1830.PubMedGoogle Scholar
  27. 27.
    Yokouchi Y, Nukaga Y, Shibasaki M, et al. Significant evidence for linkage of mite-sensitive childhood asthma to chromosome 5q31-q33 near the interleukin 12 B locus by a genome-wide search in Japanese families. Genomics. Jun 2000;66(2):152–160.PubMedCrossRefGoogle Scholar
  28. 28.
    Beyer K, Nickel R, Freidhoff L, et al. Association and linkage of atopic dermatitis with chromosome 13q12-14 and 5q31-33 markers. J Invest Dermatol. Nov 2000;115(5):906–908.PubMedCrossRefGoogle Scholar
  29. 29.
    Koppelman GH, Reijmerink NE, Colin Stine O, et al. Association of a promoter polymorphism of the CD14 gene and atopy. Am J Respir Crit Care Med. Mar 2001;163(4):965–969.PubMedGoogle Scholar
  30. 30.
    Xu J, Meyers DA, Ober C, et al. Genomewide screen and identification of gene-gene interactions for asthma-susceptibility loci in three U.S. populations: collaborative study on the genetics of asthma. Am J Hum Genet. Jun 2001;68(6):1437–1446.PubMedCrossRefGoogle Scholar
  31. 31.
    Jacobs KB, Burton PR, Iyengar SK, Elston RC, Palmer LJ. Pooling data and linkage analysis in the chromosome 5q candidate region for asthma. Genet Epidemiol. 2001;21 Suppl 1:S103–108.PubMedGoogle Scholar
  32. 32.
    Holloway JW, Lonjou C, Beghe B, et al. Linkage analysis of the 5q31-33 candidate region for asthma in 240 UK families. Genes Immun. Feb 2001;2(1):20–24.PubMedCrossRefGoogle Scholar
  33. 33.
    Mansur AH, Bishop DT, Markham AF, Britton J, Morrison JF. Association study of asthma and atopy traits and chromosome 5q cytokine cluster markers. Clin Exp Allergy. Feb 1998;28(2):141–150.PubMedCrossRefGoogle Scholar
  34. 34.
    Kamitani A, Wong ZY, Dickson P, et al. Absence of genetic linkage of chromosome 5q31 with asthma and atopy in the general population. Thorax. Sep 1997;52(9):816–817.PubMedCrossRefGoogle Scholar
  35. 35.
    Laitinen T, Kauppi P, Ignatius J, et al. Genetic control of serum IgE levels and asthma: linkage and linkage disequilibrium studies in an isolated population. Hum Mol Genet. Nov 1997;6(12):2069–2076.PubMedCrossRefGoogle Scholar
  36. 36.
    Yang IA, Fong KM, Holgate ST, Holloway JW. The role of toll-like receptors and related receptors of the innate immune system in asthma. Curr Opin Allergy Clin Immunol. Feb 2006;6(1):23–28.PubMedCrossRefGoogle Scholar
  37. 37.
    Yang IA, Savarimuthu S, Kim ST, Holloway JW, Bell SC, Fong KM. Gene-environmental interaction in asthma. Curr Opin Allergy Clin Immunol. Feb 2007;7(1):75–82.PubMedCrossRefGoogle Scholar
  38. 38.
    Woo JG, Assa'ad A, Heizer AB, Bernstein JA, Hershey GK. The -159 C-->T polymorphism of CD14 is associated with nonatopic asthma and food allergy. J Allergy Clin Immunol. Aug 2003;112(2):438–444.PubMedCrossRefGoogle Scholar
  39. 39.
    Campos E, Shimojo N, Inoue Y, et al. No association of polymorphisms in the 5 ¢ region of the CD14 gene and food allergy in a Japanese population. Allergol Int. Mar 2007;56(1):23–27.PubMedCrossRefGoogle Scholar
  40. 40.
    Nickel R, Beyer K, Huang SK, Barnes KC, Wahn U. Genetic markers of atopy in infancy: results from the German multicenter allergy study. Clin Exp Allergy. Dec 1999;29 Suppl 4:23–25.PubMedGoogle Scholar
  41. 41.
    Amoli MM, Hand S, Hajeer AH, et al. Polymorphism in the STAT6 gene encodes risk for nut allergy. Genes Immun. Jun 2002;3(4):220–224.PubMedCrossRefGoogle Scholar
  42. 42.
    Dreskin SC. Genetics of food allergy. Curr Allergy Asthma Rep. Feb 2006;6(1):58–64.PubMedCrossRefGoogle Scholar
  43. 43.
    Koppelman GH, Stine OC, Xu J, et al. Genome-wide search for atopy susceptibility genes in Dutch families with asthma. J Allergy Clin Immunol. Mar 2002;109(3):498–506.PubMedCrossRefGoogle Scholar
  44. 44.
    Klein J, Sato A. The HLA system. Second of two parts. N Engl J Med. Sep 2000;343(11):782–786.PubMedCrossRefGoogle Scholar
  45. 45.
    Shreffler WG, Charlop-Powers Z, Sicherer SH. Lack of association of HLA class II alleles with peanut allergy. Ann Allergy Asthma Immunol. Jun 2006;96(6):865–869.PubMedCrossRefGoogle Scholar
  46. 46.
    Howell WM, Turner SJ, Hourihane JO, Dean TP, Warner JO. HLA class II DRB1, DQB1 and DPB1 genotypic associations with peanut allergy: evidence from a family-based and case-control study. Clin Exp Allergy. Feb 1998;28(2):156–162.PubMedCrossRefGoogle Scholar
  47. 47.
    Hand S, Darke C, Thompson J, et al. Human leucocyte antigen polymorphisms in nut-allergic patients in South Wales. Clin Exp Allergy. May 2004;34(5):720–724.PubMedCrossRefGoogle Scholar
  48. 48.
    Dreskin SC. Do HLA genes play a role in the genetics of peanut allergy? Ann Allergy Asthma Immunol. Jun 2006;96(6):766–768.PubMedCrossRefGoogle Scholar
  49. 49.
    Kusunoki T, Okafuji I, Yoshioka T, et al. SPINK5 polymorphism is associated with disease severity and food allergy in children with atopic dermatitis. J Allergy Clin Immunol. Mar 2005;115(3):636–638.PubMedCrossRefGoogle Scholar
  50. 50.
    Magert HJ, Standker L, Kreutzmann P, et al. LEKTI, a novel 15-domain type of human serine proteinase inhibitor. J Biol Chem. Jul 1999;274(31):21499–21502.PubMedCrossRefGoogle Scholar
  51. 51.
    Nordlee JA, Taylor SL, Townsend JA, Thomas LA, Bush RK. Identification of a Brazil-nut allergen in transgenic soybeans. N Engl J Med. Mar 1996;334(11):688–692.PubMedCrossRefGoogle Scholar
  52. 52.
    Roux KH, Teuber SS, Sathe SK. Tree nut allergens. Int Arch Allergy Immunol. Aug 2003;131(4):234–244.PubMedCrossRefGoogle Scholar
  53. 53.
    van Boxtel EL, van Beers MM, Koppelman SJ, van den Broek LA, Gruppen H. Allergen Ara h 1 occurs in peanuts as a large oligomer rather than as a trimer. J Agric Food Chem. Sep 2006;54(19):7180–7186.CrossRefGoogle Scholar
  54. 54.
    Ewan PW. Clinical study of peanut and nut allergy in 62 consecutive patients: new features and associations. Bmj. Apr 1996;312(7038):1074–1078.PubMedGoogle Scholar
  55. 55.
    Kochert G, Stalker HT, Gimenes M, Galgaro L, Lopes CR, Moore K. - RFLP and cytogenetic evidence on the origin and evolution of allotetraploid domesticated peanut, arachis hypogaea (Leguminosae).- 83(- 10):- 1291.Google Scholar
  56. 56.
    Palmer GW, Dibbern DA, Jr., Burks AW, et al. Comparative potency of Ara h 1 and Ara h 2 in immunochemical and functional assays of allergenicity. Clin Immunol. Jun 2005;115(3):302–312.PubMedCrossRefGoogle Scholar
  57. 57.
    Koppelman SJ, Wensing M, Ertmann M, Knulst AC, Knol EF. Relevance of Ara h1, Ara h2 and Ara h3 in peanut-allergic patients, as determined by immunoglobulin E Western blotting, basophil-histamine release and intracutaneous testing: Ara h2 is the most important peanut allergen. Clin Exp Allergy. Apr 2004;34(4):583–590.PubMedCrossRefGoogle Scholar
  58. 58.
    Lewis SA, Grimshaw KE, Warner JO, Hourihane JO. The promiscuity of immunoglobulin E binding to peanut allergens, as determined by Western blotting, correlates with the severity of clinical symptoms. Clin Exp Allergy. Jun 2005;35(6):767–773.PubMedCrossRefGoogle Scholar
  59. 59.
    Shreffler WG, Beyer K, Chu TH, Burks AW, Sampson HA. Microarray immunoassay: association of clinical history, in vitro IgE function, and heterogeneity of allergenic peanut epitopes. J Allergy Clin Immunol. Apr 2004;113(4):776–782.PubMedCrossRefGoogle Scholar
  60. 60.
    Flinterman AE, Hoekstra MO, Meijer Y, et al. Clinical reactivity to hazelnut in children: association with sensitization to birch pollen or nuts? J Allergy Clin Immunol. Nov 2006;118(5):1186–1189.PubMedCrossRefGoogle Scholar
  61. 61.
    Alonso R, Enrique E, Pineda F, et al. An observational study on outgrowing food allergy during non-birch pollen-specific, subcutaneous immunotherapy. Int Arch Allergy Immunol. Feb 2007;143(3):185–189.PubMedCrossRefGoogle Scholar
  62. 62.
    Bucher X, Pichler WJ, Dahinden CA, Helbling A. Effect of tree pollen specific, subcutaneous immunotherapy on the oral allergy syndrome to apple and hazelnut. Allergy. Dec 2004;59(12):1272–1276.PubMedCrossRefGoogle Scholar
  63. 63.
    Beyer K, Grishina G, Bardina L, Grishin A, Sampson HA. Identification of an 11S globulin as a major hazelnut food allergen in hazelnut-induced systemic reactions. J Allergy Clin Immunol. Sep 2002;110(3):517–523.PubMedCrossRefGoogle Scholar
  64. 64.
    Schocker F, Luttkopf D, Scheurer S, et al. Recombinant lipid transfer protein Cor a 8 from hazelnut: a new tool for in vitro diagnosis of potentially severe hazelnut allergy. J Allergy Clin Immunol. Jan 2004;113(1):141–147.PubMedCrossRefGoogle Scholar
  65. 65.
    Wallowitz M, Peterson WR, Uratsu S, Comstock SS, Dandekar AM, Teuber SS. Jug r 4, a legumin group food allergen from walnut (Juglans regia Cv. Chandler). J Agric Food Chem. Oct 2006;54(21):8369–8375.PubMedCrossRefGoogle Scholar
  66. 66.
    Pastorello EA, Farioli L, Pravettoni V, et al. Lipid transfer protein and vicilin are important walnut allergens in patients not allergic to pollen. J Allergy Clin Immunol. Oct 2004;114(4):908–914.PubMedCrossRefGoogle Scholar
  67. 67.
    Zohary DaH, Maria. Domestication of plants in the old world. Oxford, United Kingdom: Oxford University Press; 2000.Google Scholar
  68. 68.
    ERS (Economic Research Service) USDoA. Fruit and tree nut yearbook spreadsheet files. [Web Page]. October, 2006; Accessed June 16, 2007.
  69. 69.
    Wang F, Robotham JM, Teuber SS, Sathe SK, Roux KH. Ana o 2, a major cashew (Anacardium occidentale L.) nut allergen of the legumin family. Int Arch Allergy Immunol. Sep 2003;132(1):27–39.PubMedCrossRefGoogle Scholar
  70. 70.
    Clark AT, Ewan PW. The development and progression of allergy to multiple nuts at different ages. Pediatr Allergy Immunol. Sep 2005;16(6):507–511.PubMedCrossRefGoogle Scholar
  71. 71.
    Goetz DW, Whisman BA, Goetz AD. Cross-reactivity among edible nuts: double immunodiffusion, crossed immunoelectrophoresis, and human specific igE serologic surveys. Ann Allergy Asthma Immunol. Jul 2005;95(1):45–52.PubMedCrossRefGoogle Scholar
  72. 72.
    de Leon MP, Drew AC, Glaspole IN, Suphioglu C, Rolland JM, O'Hehir RE. Functional analysis of cross-reactive immunoglobulin E antibodies: peanut-specific immunoglobulin E sensitizes basophils to tree nut allergens. Clin Exp Allergy. Aug 2005;35(8):1056–1064.CrossRefGoogle Scholar
  73. 73.
    de Leon MP, Drew AC, Glaspole IN, Suphioglu C, O'Hehir RE, Rolland JM. IgE cross-reactivity between the major peanut allergen Ara h 2 and tree nut allergens. Mol Immunol. Jan 2007;44(4):463–471.CrossRefGoogle Scholar
  74. 74.
    Bernhisel-Broadbent J, Taylor S, Sampson HA. Cross-allergenicity in the legume botanical family in children with food hypersensitivity. II. Laboratory correlates. J Allergy Clin Immunol. Nov 1989;84(5 Pt 1):701–709.PubMedCrossRefGoogle Scholar
  75. 75.
    Bernhisel-Broadbent J, Sampson HA. Cross-allergenicity in the legume botanical family in children with food hypersensitivity. J Allergy Clin Immunol. Feb 1989;83(2 Pt 1):435–440.PubMedCrossRefGoogle Scholar
  76. 76.
    Clark AT, Ewan PW. Interpretation of tests for nut allergy in one thousand patients, in relation to allergy or tolerance. Clin Exp Allergy. Aug 2003;33(8):1041–1045.PubMedCrossRefGoogle Scholar
  77. 77.
    Ho MH, Heine RG, Wong W, Hill DJ. Diagnostic accuracy of skin prick testing in children with tree nut allergy. J Allergy Clin Immunol. Jun 2006;117(6):1506–1508.PubMedCrossRefGoogle Scholar
  78. 78.
    Sporik R, Hill DJ, Hosking CS. Specificity of allergen skin testing in predicting positive open food challenges to milk, egg and peanut in children. Clin Exp Allergy. Nov 2000;30(11):1540–1546.PubMedCrossRefGoogle Scholar
  79. 79.
    Wainstein BK, Yee A, Jelley D, Ziegler M, Ziegler JB. Combining skin prick, immediate skin application and specific-IgE testing in the diagnosis of peanut allergy in children. Pediatr Allergy Immunol. May 2007;18(3):231–239.PubMedCrossRefGoogle Scholar
  80. 80.
    Akkerdaas JH, Wensing M, Knulst AC, et al. How accurate and safe is the diagnosis of hazelnut allergy by means of commercial skin prick test reagents? Int Arch Allergy Immunol. Oct 2003;132(2):132–140.PubMedCrossRefGoogle Scholar
  81. 81.
    Senna G, Bonadonna P, Crivellaro M, Schiappoli M, Passalacqua G. Anaphylaxis due to Brazil nut skin testing in a walnut-allergic subject. J Investig Allergol Clin Immunol. 2005;15(3):225–227.PubMedGoogle Scholar
  82. 82.
    Bernstein DI, Wanner M, Borish L, Liss GM. Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990–2001. J Allergy Clin Immunol. Jun 2004;113(6):1129–1136.PubMedCrossRefGoogle Scholar
  83. 83.
    Astier C, Morisset M, Roitel O, et al. Predictive value of skin prick tests using recombinant allergens for diagnosis of peanut allergy. J Allergy Clin Immunol. Jul 2006;118(1):250–256.PubMedCrossRefGoogle Scholar
  84. 84.
    Perry TT, Matsui EC, Kay Conover-Walker M, Wood RA. The relationship of allergen-specific IgE levels and oral food challenge outcome. J Allergy Clin Immunol. Jul 2004;114(1):144–149.PubMedCrossRefGoogle Scholar
  85. 85.
    Fleischer DM, Conover-Walker MK, Matsui EC, Wood RA. The natural history of tree nut allergy. J Allergy Clin Immunol. 2005;116(5):1087–1093.PubMedCrossRefGoogle Scholar
  86. 86.
    Sampson HA. Utility of food-specific IgE concentrations in predicting symptomatic food allergy. J Allergy Clin Immunol. May 2001;107(5):891–896.PubMedCrossRefGoogle Scholar
  87. 87.
    Sampson HA, Ho DG. Relationship between food-specific IgE concentrations and the risk of positive food challenges in children and adolescents. J Allergy Clin Immunol. Oct 1997;100(4):444–451.PubMedCrossRefGoogle Scholar
  88. 88.
    Skolnick HS, Conover-Walker MK, Koerner CB, Sampson HA, Burks W, Wood RA. The natural history of peanut allergy. J Allergy Clin Immunol. Feb 2001;107(2):367–374.PubMedCrossRefGoogle Scholar
  89. 89.
    Fleischer DM, Conover-Walker MK, Christie L, Burks AW, Wood RA. The natural progression of peanut allergy: resolution and the possibility of recurrence. J Allergy Clin Immunol. Jul 2003;112(1):183–189.PubMedCrossRefGoogle Scholar
  90. 90.
    Fleischer DM, Conover-Walker MK, Christie L, Burks AW, Wood RA. Peanut allergy: recurrence and its management. J Allergy Clin Immunol. Nov 2004;114(5):1195–1201.PubMedCrossRefGoogle Scholar
  91. 91.
    Taylor SL, Hefle SL. Food allergen labeling in the USA and Europe. Curr Opin Allergy Clin Immunol. Jun 2006;6(3):186–190.PubMedCrossRefGoogle Scholar
  92. 92.
    Moingeon P, Batard T, Fadel R, Frati F, Sieber J, Van Overtvelt L. Immune mechanisms of allergen-specific sublingual immunotherapy. Allergy. Feb 2006;61(2):151–165.PubMedCrossRefGoogle Scholar
  93. 93.
    Larche M, Akdis CA, Valenta R. Immunological mechanisms of allergen-specific immuno-therapy. Nat Rev Immunol. Oct 2006;6(10):761–771.PubMedCrossRefGoogle Scholar
  94. 94.
    Bullock RJ, Barnett D, Howden ME. Immunologic and clinical responses to parenteral immunotherapy in peanut anaphylaxis–a study using IgE and IgG4 immunoblot monitoring. Allergol Immunopathol (Madr). Sep–Oct 2005;33(5):250–256.CrossRefGoogle Scholar
  95. 95.
    Nelson HS, Lahr J, Rule R, Bock A, Leung D. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J Allergy Clin Immunol. Jun 1997;99(6 Pt 1):744–751.PubMedCrossRefGoogle Scholar
  96. 96.
    Gidaro GB, Marcucci F, Sensi L, Incorvaia C, Frati F, Ciprandi G. The safety of sublingual-swallow immunotherapy: an analysis of published studies. Clin Exp Allergy. May 2005;35(5):565–571.PubMedCrossRefGoogle Scholar
  97. 97.
    Buchanan AD, Green TD, Jones SM, et al. Egg oral immunotherapy in nonanaphylactic children with egg allergy. J Allergy Clin Immunol. Jan 2007;119(1):199–205.PubMedCrossRefGoogle Scholar
  98. 98.
    Meglio P, Bartone E, Plantamura M, Arabito E, Giampietro PG. A protocol for oral desensi-tization in children with IgE-mediated cow's milk allergy. Allergy. Sep 2004;59(9): 980–987.PubMedCrossRefGoogle Scholar
  99. 99.
    de Boissieu D, Dupont C. Sublingual immunotherapy for cow's milk protein allergy: a preliminary report. Allergy. Oct 2006;61(10):1238–1239.PubMedCrossRefGoogle Scholar
  100. 100.
    Enrique E, Pineda F, Malek T, et al. Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract. J Allergy Clin Immunol. Nov 2005;116(5):1073–1079.PubMedCrossRefGoogle Scholar
  101. 101.
    Mansfield L. Successful oral desensitization for systemic peanut allergy. Ann Allergy Asthma Immunol. Aug 2006;97(2):266–267.PubMedCrossRefGoogle Scholar
  102. 102.
    Patriarca G, Nucera E, Pollastrini E, et al. Oral rush desensitization in peanut allergy: a case report. Dig Dis Sci. Mar 2006;51(3):471–473.PubMedCrossRefGoogle Scholar
  103. 103.
    Scurlock AM, Steele, P.H., Andrzejewski, S.S., Pons, L.A., Althage, K.A., Christie, L., Carlisle, S.K., Buchanan, A.D., Jones, S.M., Burks, A.W. Safety of oral peanut immuno-therapy for peanut allergic patients. J Allergy Clin Immunol. Feb 2005:S246Google Scholar
  104. 104.
    Pons L, Burks W. Novel treatments for food allergy. Expert Opin Investig Drugs. Jul 2005;14(7):829–834.PubMedCrossRefGoogle Scholar
  105. 105.
    Leung DY, Sampson HA, Yunginger JW, et al. Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med. Mar 2003;348(11):986–993.PubMedCrossRefGoogle Scholar
  106. 106.
    Novartis UoMMC. Safety and Efficacy Study of Omalizumab Given Prior to Immunotherapy. In: [Internet]. NLM Identifier: NCT00329381, 2000-[cited 2007 Jun 16].
  107. 107.
    Administration USFaD. Omalizumab (marked as Xolair) Information. [Web Page]. Feb 2007; Accessed June 16, 2007.
  108. 108.
    Li XM, Zhang TF, Huang CK, et al. Food Allergy Herbal Formula-1 (FAHF-1) blocks peanut-induced anaphylaxis in a murine model. J Allergy Clin Immunol. Oct 2001;108(4):639–646.PubMedCrossRefGoogle Scholar
  109. 109.
    Li XM, Srivastava K. Traditional Chinese medicine for the therapy of allergic disorders. Curr Opin Otolaryngol Head Neck Surg. Jun 2006;14(3):191–196.PubMedCrossRefGoogle Scholar
  110. 110.
    Srivastava KD, Kattan JD, Zou ZM, et al. The Chinese herbal medicine formula FAHF-2 completely blocks anaphylactic reactions in a murine model of peanut allergy. J Allergy Clin Immunol. Jan 2005;115(1):171–178.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2009

Authors and Affiliations

  1. 1.Department of Pediatrics, Division of Pediatric Allergy and ImmunologyJohns Hopkins University School of MedicineBaltimoreUSA
  2. 2.Department of Pediatrics, Division of Allergy and ImmunologyJohns Hopkins University School of MedicineUSA
  3. 3.Johns Hopkins HospitalBaltimoreUSA

Personalised recommendations